You have been chosen to receive this valuable information.
Image
Image
You are developing a monoclonal antibody and your time to develop is limited. But have you considered the impact of your decisions as you are developing upstream?
At CPhI Worldwide in Frankfurt, learn how Lonza Pharma & Biotech can help you successfully navigate these challenges to advance your molecule, simplify your outsourcing experience and meet your commercial objectives
Join our subject matter experts for the Tech Talks sessions in Lonza booth no. 121C10
On Tuesday, 5 November 2019
10:15 Particle engineering for inhaled dosage forms – Eduardo Jule
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Technology, a MJH Life Sciences™. You are on the mailing list as %%emailaddress%%.